Flerie AB has approved the transfer of its Limited Partnership holdings to T&M Participation AB, enhancing liquidity and reducing financial obligations.

Target Company Overview

Flerie AB is a dynamic and long-term investor specializing in the Life Science sector, maintaining a diversified portfolio of innovative companies with groundbreaking technologies. The firm focuses on global investments in companies engaged in product development and commercial growth, often alongside other prominent investors, particularly in challenging-to-access private companies.

Flerie employs an active ownership model, leveraging extensive networks and resources to support and expedite the advancement of its portfolio companies' projects, ultimately creating shareholder value. Flerie AB's common shares are listed on Nasdaq Stockholm under the ticker FLERIE.

Industry Overview in Sweden

The Life Science industry in Sweden is a vibrant and growing sector, characterized by a strong focus on research and development. Sweden has established itself as a leader in biotech and pharmaceuticals, benefiting from a suppor